**Core Concept**
Apo E deficiency is a rare autosomal recessive disorder causing impaired clearance of chylomicrons and very-low-density lipoproteins (VLDL) from the bloodstream due to defective receptor-mediated endocytosis. This leads to accumulation of lipoproteins, especially chylomicrons and intermediate-density lipoproteins (IDL), resulting in hypertriglyceridemia, xanthomas, and accelerated atherosclerosis.

**Why the Correct Answer is Right**
In Apo E deficiency, the apolipoprotein E (Apo E) protein, which is essential for binding lipoproteins to the LDL receptor and hepatic clearance, is absent or deficient. This disrupts the normal metabolism of chylomicrons and IDL, leading to their prolonged circulation. Elevated triacylglycerols and IDL are hallmark findings. Palmar xanthomas develop due to lipid accumulation in skin lesions, and patients are at high risk of atherosclerosis and coronary artery disease (CAD). This condition is also associated with type III hyperlipoproteinemia (familial dysbetalipoproteinemia).

**Why Each Wrong Option is Incorrect**
Option A: LDL deficiency is not the cause; in fact, LDL is elevated in Apo E deficiency due to impaired clearance, not deficiency.
Option B: VLDL overproduction is not the primary defect; while VLDL may be elevated, the root issue is impaired clearance, not overproduction.
Option C: Apo C-2 deficiency primarily affects lipoprotein lipase activity and is linked to hypertriglyceridemia, but it does not cause IDL accumulation or xanthomas like Apo E deficiency.

**Clinical Pearl / High-Yield Fact**
Apo E deficiency is a key cause of type III hyperlipoproteinemia — remember: "E" stands for "Elevated IDL and chylomicrons" and "Xanthomas" — so **"E = Xanthomas, Elevated IDL, Atherosclerosis"**.

✓ Correct Answer: D. Apo E deficiency